Lawrence Russell Smith, VP, Vaccine Research at VICAL INC (VICL), bought 90,000 shares at $1.42 ($128K) on 2014-01-10, disclosed to the SEC on 2014-01-14.
Open-market purchase of $128k VICL by VP, Vaccine Research. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| VICL | SELL | 2017-01-13 | $134 | — | Filing → |
| VICL | SELL | 2016-10-12 | $165 | — | Filing → |
| VICL | SELL | 2016-07-13 | $241 | — | Filing → |